Cynical Bear has been in touch to flag up more strange money go round happenings in the Standard List mini empire of worthless shell companies controlled by Charles Tatnall. For Fandango Holdings (FHP) has just released its results for calendar 2018.  It loks grim but also odd.

Writing on industrial components and consumables manufacturer Synnovia (SYN) - Plastics Capital as was - in February, I questioned is a 10%+ forecast reduction really “broadly in line”?!. Now a “Trading Update and Restatement of Accounts”. Uh oh…

Hello the global earnings season. This is a quarterly reality which makes my life periodically very busy...but what could be more interesting than zoning into the latest thoughts of a bunch of corporations around the world? Three in the UK market capture my attention today…

RBS (RBS) has announced that after five and a half years of earning a basic salary of a million quid a year plus numerous bonuses, LTIPs etc, Ross McEwan has resigned from his role as Chief Executive Officer (CEO) and Executive Director. We are told that bankster fat cat Ross is on a 12 month notice period.

In many ways the announcement of more confetti from AIM-listed Minoan (MIN) is a big disappointment. After all, it has an asset worth many times its market capitalisation, several multiples of the enterprise value and is also carried on the books in the recent (audited) full-year results at heavy multiples of market cap and EV. And we are told that there are interested parties who want a piece of the action – so why not just sell it? Well, it is more complicated than that...

Hello, Share Plungers. Here’s a company which should please green investors. Its aim is to bring cleaner and cheaper energy to businesses, homes and vehicles. Ceres Power (CWR) researches and makes fuel cells...

Thanks for all your emails, fellow shareholders. I had indeed noticed that shares in Wishbone Gold (WSBN) were down by c27% today at 0.07p and so put in a call to Richard Poulden.

A “New $3.48m USD Contract Award - Asia” announcement from Westminster Group (WSG) – with Chief Executive Peter Fowler “delighted to be able to announce this latest new contract award for large scale screening solutions, which has been secured after a prolonged period of negotiations” and the shares currently higher, towards 9p, in response. Hmmm…

In today's bearcast I cover Optibiotix (OPTI), Vela (VELA), Woodford Patient Capital trust (WPCT), Ascent Resources (AST), Mosman Oil & Gas (MSMN), Management Resource Solutions (MRS), Bidstack (BIDS) and Optiva/Novum and a hot City rumour. Also I have a message for 90% of listeners - please be a hero today, my 21 mile training walk for this weekend has been planned so donate to Rogue Bloggers for Woodlarks HERE

Let us be clear: Johnny Mercer, the Tory MP is not involved in the London & Capital Finance scandal which we have done so much to expose. But he is personally profiting from what will prove to be the financial scandal of the year, the mini-bond mis-selling affair, and his reaction to criticism of his behaviour is lamentable.

Bioplastics and radio frequency technology business, Biome Technologies (BIOM) has updated including that “2019 has commenced in an encouraging manner, particularly for the Bioplastics division” – and the shares have currently responded higher to 380p, though still well down from their approaching 700p in January…

Smaller North Sea oil and gas companies seem to be out of favour, as investors go chasing big profits in riskier, less proven parts of the world, but more often than not the outcome tends to be heavy losses on these types of outfits.

Ascent Resources (AST) “is pleased to announce that it has completed an oversubscribed placing of 214,285,714 ordinary shares… with a small number of institutional investors. The placing was conducted at a price of 0.35 pence per share”. Particular credit to Evil Banksta – and the company “pleased to announce”, with the price a 30% discount to the prior close?! (“oversubscribed” not exactly an achievement then!)...

Optibiotix (OPTI) has announced the launch of SlimBiome® Medical in the UK – as of 29 April.  All; well and good and I remain an enthusiast for the shares - they are cheap. But there is another matter which is not so impressive in a word where transparency is now universally viewed as critical.

The investment case for Purplebricks (PURP) is looking increasingly ragged. Even the analysts, not noted for being quick off the mark, seem to be losing faith – JP Morgan slashing its price target from 400p to 188p, and Berenberg really coming to its senses by replacing its 460p target with an 80p target. The disruptive growth story is now in shreds after February’s profit warning...

Direct Line Insurance (DLG) is a rather unusual company. It does not flog its policies on comparison websites. You would think this would reduce the size of premiums. But when I compared the cost of insuring my jalopy, admittedly some months ago, I found I got a few better offers from comparison sites...

Perhaps in 20 days time limp dick sad excuse for a journalist, the liar, Jamie Nimmo of the Mail On Sunday will report on this development at Argo Blockchain (ARB) and tell his dwindling readership that “he can reveal”. I can reveal the board has been given the option of buying the underlying crypto business for just £1.

The great success that was the 2019 Global Group UK Investor Show saw three 'Dragon's Den' sessions where a number of CEOs each gave a 1 minute (well, supposed to be!) pitch and three 'Dragons' at each session each picked a stock for a £1,000 investment. With the show having been in the last week of March, here’s a first performance update...

I have known for a while that Yourgene (YGEN) was to upgrade its broker from FinnCrap to Stifel. It is a big upgrade. But I was told that FinnCap would be kept on as joint broker for three months during part of which Stifel is in a research blackout period. Something happened last Wednesday and FinnCap was fired with immediate effect. I shall endeavour to establish what it was but maybe it was just that FinnCrap’s last research note was so bad that it was felt that no research for 40 days was better than another note from the same shite analyst. Perhaps FinnCap did something worse. I am digging. What you, my fellow shareholders want to know about is the placing and acquisition.

Previously updating on point of sale, payment and loyalty systems group Universe (UNG) just over a year ago with the shares lower towards 5p, I wrote 2017 results, outlook “solid”… other than a “significant uncertainty”! – concluding I awaited a more reassuring announcement before considering from the watchlist. Recent results have now been followed by a “Directorate Change”…